April 26, 2018 22:00 UTC Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China --DIAN Designated Roche’s and Foundation Medicine’s Exclusive Clinical Sequencing Partner in China-- --Roche will Commercialize Foundation Medicine’s Comprehensive Genomic Profiling Tests in China-- CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Foundation Medicine, Inc. , (NASDAQ:
April 26, 2018
· 5 min read
